Adult cystic fibrosis patients with and without infective exacerbations and their factor XII levels

Blood Coagulation and Fibrinolysis

Volumn 20, Issue 6, 2009, Pages 400-402

  Davidson, Simon J ^a   Paramothayan, Shanti ^a   Hodson, Margaret E ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Cystic fibrosis; Factor XII; Inflammation

Indexed keywords

ALBUMIN; ANTITHROMBIN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6;

ADULT; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; MAJOR CLINICAL STUDY; NEUTROPHIL; PRIORITY JOURNAL;

ACUTE-PHASE PROTEINS; ADULT; ANTITHROMBIN III; BLOOD COAGULATION FACTORS; CYSTIC FIBROSIS; DISEASE SUSCEPTIBILITY; FACTOR VIII; FACTOR XII; FACTOR XII DEFICIENCY; FACTOR XIIA; FEMALE; FIBRINOGEN; HEMOSTASIS; HUMANS; INFECTION; INFLAMMATION; INTERLEUKIN-6; LIVER; MALE;

EID: 69549126901     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283249ac6     Document Type: Article

References (15)

1. Davidson SJ, Burman JF, Davies J, Bush A. Cystic fibrosis and factor XII deficiency. Thromb Haemost 1997; (Suppl):214.
2. Komp DM, Selden RF. Coagulation abnormalities in cystic fibrosis. Chest 1970; 58:501-503.
3. O'Sullivan BP, Linden MD, Frelinger AL 3rd, Barnard MR, Spencer-Manzon M, Morris JE, et al. Platelet activation in cystic fibrosis. Blood 2005; 105:4635-4641.
4. O'Sullivan BP, Michelson AD. The inflammatory role of platelets in cystic fibrosis. Am J Respir Crit Care Med 2006; 173:483-490.
5. Falco A, Romano M, Iapichino L, Collura M, Davì G. Increased soluble CD40 ligand levels in cystic fibrosis. J Thromb Haemost 2004; 2:557-560. (Pubitemid 40185678)
6. Gordon EM, Venkatesan N, Salazar R, Tang H, Schmeidler-Sapiro K, Buckley S, et al. Factor XII-induced mitogenesis is mediated via a distinct signal transduction pathway that activates a mitogen-activated protein kinase. Proc Natl Acad Sci U S A 1996; 93:2174-2179. (Pubitemid 26079901)
7. Johnson K, Choi Y, DeGroot E, Samuels I, Creasey A, Aarden L. Potential mechanism for a proinflammatory vascular cytokine response to coagulation activation. J Immunol 1998; 160:5130-5135. (Pubitemid 28215352)
8. Citarella F, Felici A, Brouwer M, Wagstaff J, Fantoni A, Hack. Interleukin-6 downregulates factor XII production by human hepatoma cell line (HepG2). Blood 1997; 90:1501-1507.
9. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990; 265:621-636.
10. Niessen RWLM, Lamping RJ, Jansen PM, Prins MH, Peters M, Taylor FB, et al. Antithrombin acts as a negative acute phase protein as established with studies on HepG2 cells and baboons. Thromb Haemost 1997; 78:1088-1092. (Pubitemid 27417305)
11. Iatridis SG, Ferguson JH. Effect of surface and Hageman factor on the endogenous or spontaneous activation of the fibrinolytic system. Thromb Diath Haemorr 1961; 6:411-423.
12. Lammle B, Wuillemin WA, Huber I, Krauskopf M, Zurcher C, Pflugshaupt R, Furlan M. Thromboembolism and bleeding tendency in congenital factor XII deficiency: a study on 74 subjects from 14 Swiss families. Thromb Haemost 1991; 65:117-121.
13. Rodeghiero F, Castaman G, Ruggeri M, Tosetto A. Thrombosis in subjects with homozygous and heterozygous factor XII deficiency. Thromb Haemost 1992; 67:590-591.
14. Colman RW, Wong PY. Participation of Hageman factor dependent pathways in human disease states. Thromb Haemost 1977; 38:751-775.
15. Yamamoto T, Shibuya Y, Nishino N, Okabe H, Kambara T. Activation of human Hageman factor by Pseudomonas aeruginosa elastase in the presence or absence of negatively charged substance in vitro. Biochim Biophys Acta 1990; 1038:231-239. (Pubitemid 20135870)